Global Closed System Drug Transfer Device (CSTD) Market Research Report - Forecast till 2027

PUBLISHED: October 3, 2022

PAGES: 110 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

Market Overview

The CAGR for the closed system drug transfer devices market is projected to be 19.10% until 2027. The market esteem is projected to be USD 8.95 billion by 2027.

Closed system drug transfer devices are important for specialists since they safeguard them from coincidentally being infused with hazardous drugs. These devices transfer unsafe drugs and their fumes into another system where they are entangled and can't influence individuals.

The closed system drug transfer devices market is encountering an extremely high CAGR predominantly considering the fast expansion in disease cases. As individuals live longer, they are bound to get malignant growth as they age. Additionally, many individuals smoked in their more youthful years. This can and causes different sorts of malignant growth as they age.

The closed system drug transfer devices market esteem is supposed to be USD 1.62 billion every 2027. The CAGR for this market is projected to be 20.27%. This is principally ascribed to areas of strength in a few market fragments.

The closed system drug transfer devices market has not had many restrictions. One of the primary factors that are keeping down development is the high predominance of clinical devices that either doesn't fill in as well as they ought to or don't function as they were intended to. A significant number of these devices will generally spill out hazardous and strong drugs too. At long last, openness to these drugs can make medical care laborers become fruitless rapidly.

Segment overview

The global closed system drug transfer device market is classified in terms of system, application, and end user.

The closed system drug transfer devices market can be divided into the following sub-segments based on application Nursing, Pharmacy, and Veterinary. The closed-system drug transfer devices market can be divided into the following sub-segments based on end-user Distribution channel

Regional Analysis

The North American district has the prevailing market share in the closed-system drug transfer devices market. America overwhelms as far as market share around here. The explanation is that it has a developed and mind-boggling/complex medical services system. Its emergency clinics are likewise a portion of the dominates on the planet. This country likewise burns through huge amount of cash on public and confidential medical services. It likewise has probably the best examination offices on the planet with regards to medication and clinical consideration.

The development rate in the Asia-Pacific district won't be major areas of strength for as on the grounds that the closed-system drug transfer devices market isn't vigorously controlled. Likewise, the states in most Asian countries don't focus on medical services spending, however their spending on medical services has expanded considerably lately.

Major Companies

The major players in the closed system drug transfer devices market include Becton - USA, Dickinson, and Company (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Equashield LLC (U.S.), ICU Medical Inc. (U.S.), Yukon Medical (U.S.), and Corvida Medical (U.S.)

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Product Code: MRFR/HC/6264-CR

1 REPORT PROLOGUE

2 MARKET INTRODUCTION

2.1 INTRODUCTION 15
2.2 ASSUMPTIONS & LIMITATIONS 15
- 2.2.1 ASSUMPTIONS 15
- 2.2.2 LIMITATIONS 15
2.3 MARKET STRUCTURE 15

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS 17
3.2 PRIMARY RESEARCH 18
3.3 SECONDARY RESEARCH 19
3.4 MARKET SIZE ESTIMATION 19
3.5 FORECAST MODEL 20

4 MARKET DYNAMICS

4.1 INTRODUCTION 22
4.2 DRIVERS 23
- 4.2.1 RISING PREVALENCE OF CANCER CASES 23
- 4.2.2 INCREASED RISK OF EXPOSURE TO HAZARDOUS DRUGS FOR HEALTHCARE PERSONNEL 23
- 4.2.3 SEVERAL SAFETY GUIDELINES AND LEGISLATION FOR THE USE OF CSTD 23
4.3 RESTRAINTS 24
- 4.3.1 HIGH COST 24
- 4.3.2 ADVERSE EVENTS AND STATUTORY WARNING BY FDA FOR THE USE OF CSTD 24
4.4 OPPORTUNITY 24
- 4.4.1 EMERGING MARKETS OF CSTD 24

5 MARKET FACTOR ANALYSIS

5.1 PORTER'S FIVE FORCES ANALYSIS 26
- 5.1.1 BARGAINING POWER OF SUPPLIERS 26
- 5.1.2 BARGAINING POWER OF BUYERS 27
- 5.1.3 THREAT OF NEW ENTRANTS 27
- 5.1.4 THREAT OF SUBSTITUTES 27
- 5.1.5 INTENSITY OF RIVALRY 27
5.2 SUPPLY CHAIN ANALYSIS 27
- 5.2.1 R&D 28
- 5.2.2 MANUFACTURING 28
- 5.2.3 DISTRIBUTION 28
- 5.2.4 MARKETING & SALES 28
- 5.2.5 POST-SALES MONITORING 28
5.3 INVESTMENT OPPORTUNITIES 28
5.4 PRICING ANALYSIS 29
5.5 MARKETING CHANNEL 29
- 5.5.1 DIRECT MARKETING 29
- 5.5.2 INDIRECT MARKETING 29
5.6 REGULATORY AFFAIRS 29
5.7 COST OF PRODUCTION ANALYSIS 30
- 5.7.1 RAW MATERIAL COST ANALYSIS 31
- 5.7.2 TECHNOLOGY COST ANALYSIS 31
- 5.7.3 LABOR COST ANALYSIS 31

6 CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE

6.1 OVERVIEW 33
- 6.1.1 INTRODUCTION 33
- 6.1.2 BARRIER-TYPE 35
- 6.1.3 FILTRATION-TYPE 35

7 CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY

7.1 OVERVIEW 37
- 7.1.1 INTRODUCTION 37
- 7.1.2 CLOSED BAG/LINE ACCESS DEVICES 39
- 7.1.3 CLOSED VIAL ACCESS DEVICES 39
- 7.1.4 CLOSED SYRINGE SAFETY DEVICES 40

8 CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER

8.1 OVERVIEW 42
- 8.1.1 INTRODUCTION 42
- 8.1.2 SPECIALTY CENTERS 43
- 8.1.3 HOSPITALS & CLINICS 44